BioWorld MedTech

April 15, 2014

Medtronic faces debilitating U.S. injunction on CoreValve sales

Edwards Lifesciences (Irvine, California) has won an important battle in a six-year patent war with Medtronic (Minneapolis) over Medtronic's CoreValve transcatheter aortic valve replacement (TAVR/TAVI) system. Read More

Financings Roundup: Sant Ventures boosts size of most recent fund to $139 million

Final data from PRECISE trial to bepublished in American Heart Journal

Washington Roundup: Importers beware; Health Canada report cites SOPs for distribution

International report: Chiyoda Technol to distribute Mevion's S250 in Japan

Agreements/contracts: SBG Technology Solutions awarded VA contract extension for VistA

Deals roundup: Chindex receives M&A cash bid from buyer consortium

HIT Roundup: Osler to use Medworxx patient flow platform

Syneron gets clearance for UltraShape system

Product briefs

Briefly Noted

People in Places

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for May 22, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Roche reports new TREM2 agonists

BioWorld Science

F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...

Genescience presents STAT6 degrader for atopic dermatitis

BioWorld Science

Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....

Sangamo presents primate data for prion suppressor ST-506

BioWorld Science

Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...